These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 12239229)

  • 21. The PROTEKT surveillance study: antimicrobial susceptibility of Haemophilus influenzae and Moraxella catarrhalis from community-acquired respiratory tract infections.
    Hoban D; Felmingham D
    J Antimicrob Chemother; 2002 Sep; 50 Suppl S1():49-59. PubMed ID: 12239228
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Outcomes in lower respiratory tract infections and the impact of antimicrobial drug resistance.
    Metlay JP; Singer DE
    Clin Microbiol Infect; 2002; 8 Suppl 2():1-11. PubMed ID: 12427205
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Safeguarding future antimicrobial options: strategies to minimize resistance.
    Leclercq R
    Clin Microbiol Infect; 2001; 7 Suppl 3():18-23. PubMed ID: 11523557
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A multicentre collaborative study of the antimicrobial susceptibility of community-acquired, lower respiratory tract pathogens 1992-1993: the Alexander Project.
    Felmingham D; Grüneberg RN
    J Antimicrob Chemother; 1996 Jul; 38 Suppl A():1-57. PubMed ID: 8858472
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical management of respiratory tract infections in the community: experience with telithromycin.
    Quintiliani R
    Infection; 2001 Dec; 29 Suppl 2():16-22. PubMed ID: 11785852
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Novel cost-effective approaches to the treatment of community-acquired infections.
    Schwarzmann SW
    Ann Pharmacother; 1998 Jan; 32(1):S27-30. PubMed ID: 9475837
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical implications and treatment of multiresistant Streptococcus pneumoniae pneumonia.
    File TM
    Clin Microbiol Infect; 2006 May; 12 Suppl 3():31-41. PubMed ID: 16669927
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Geminofloxacin for the management of community-acquired respiratory tract infections.
    Blondeau JM; Tillotson G; Deangelis J
    J Chemother; 2006 Dec; 18(6):582-8. PubMed ID: 17267335
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Alexander Project 1996-1997: latest susceptibility data from this international study of bacterial pathogens from community-acquired lower respiratory tract infections.
    Felmingham D; Grüneberg RN
    J Antimicrob Chemother; 2000 Feb; 45(2):191-203. PubMed ID: 10660501
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antibacterial resistance of community-acquired respiratory tract pathogens recovered from patients in Germany and activity of the Ketolide Telithromycin: results from the PROTEKT surveillance study (1999-2000).
    Reinert RR; Rodloff AC; Halle E; Baer W; Beyreiss B; Seifert H; Wichelhaus TA; Maass M; Mehl M
    Chemotherapy; 2004 Jun; 50(3):143-51. PubMed ID: 15272227
    [TBL] [Abstract][Full Text] [Related]  

  • 31. AWARE Ceftaroline Surveillance Program (2008-2010): trends in resistance patterns among Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis in the United States.
    Pfaller MA; Farrell DJ; Sader HS; Jones RN
    Clin Infect Dis; 2012 Sep; 55 Suppl 3():S187-93. PubMed ID: 22903951
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evidence-based guidelines for treatment of bacterial respiratory tract infections in the era of antibiotic resistance.
    Jacobs MR; Weinberg W
    Manag Care Interface; 2001 Apr; 14(4):68-80. PubMed ID: 11339025
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A multicenter study of the antimicrobial susceptibility of Haemophilus influenzae, Streptococcus pneumoniae, and Moraxella catarrhalis isolated from patients with community-acquired lower respiratory tract infections in 1999 in Portugal.
    Melo-Cristino J; Fernandes ML; Serrano N;
    Microb Drug Resist; 2001; 7(1):33-8. PubMed ID: 11310801
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antibacterial activity and PK/PD of ceftriaxone against penicillin-resistant Streptococcus pneumoniae and beta-lactamase-negative ampicillin-resistant Haemophilus influenzae isolates from patients with community-acquired pneumonia.
    Ohno A; Ishii Y; Kobayashi I; Yamaguchi K
    J Infect Chemother; 2007 Oct; 13(5):296-301. PubMed ID: 17982717
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vitro activity of cefditoren and other comparators against Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis causing community-acquired respiratory tract infections in China.
    Yang Q; Xu Y; Chen M; Wang H; Sun H; Hu Y; Zhang R; Duan Q; Zhuo C; Cao B; Liu Y; Yu Y; Sun Z; Chu Y
    Diagn Microbiol Infect Dis; 2012 Jun; 73(2):187-91. PubMed ID: 22521692
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Resistance surveillance of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis isolated in the United States, 1997-1998.
    Thornsberry C; Jones ME; Hickey ML; Mauriz Y; Kahn J; Sahm DF
    J Antimicrob Chemother; 1999 Dec; 44(6):749-59. PubMed ID: 10590275
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Therapeutic options for pneumococcal pneumonia in Turkey.
    Oncu S; Erdem H; Pahsa A
    Clin Ther; 2005 Jun; 27(6):674-83. PubMed ID: 16117975
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Multicenter surveillance of antimicrobial resistance of Streptococcus pyogenes, Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis to 14 oral antibiotics.
    Hsueh PR; Huang WK; Shyr JM; Lau YJ; Liu YC; Luh KT
    J Formos Med Assoc; 2004 Sep; 103(9):664-70. PubMed ID: 15361938
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Therapeutic options among broad-spectrum beta-lactams for infections caused by levofloxacin-nonsusceptible Streptococcus pneumoniae.
    Jones RN; Fritsche TR; Sader HS
    Diagn Microbiol Infect Dis; 2005 Jun; 52(2):129-33. PubMed ID: 15964501
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Microbiological and pharmacodynamic considerations in the treatment of infection due to antimicrobial-resistant Streptococcus pneumoniae.
    Appelbaum PC
    Clin Infect Dis; 2000 Aug; 31 Suppl 2():S29-34. PubMed ID: 10984325
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.